Urinary and Circulating Tumor DNA in Muscle-Invasive Bladder Cancer: NIAGARA Data
Project Oncology®Urinary and Circulating Tumor DNA in Muscle-Invasive Bladder Cancer: NIAGARA Data
Charles Turck, PharmD, BCPS, BCCCP
Petros Grivas, MD, PhD
Charles Turck, PharmD, BCPS, BCCCP
Harish Gagneja, MD
Rohit Singhania, MD
Rethinking IBS-C Goals: A Patient-Centered Approach
GI InsightsRethinking IBS-C Goals: A Patient-Centered Approach
Charles Turck, PharmD, BCPS, BCCCP
Harish Gagneja, MD
Rohit Singhania, MD
Real-World Cases in Squamous Cell Carcinoma of the Anal Canal Care
Project Oncology®Real-World Cases in Squamous Cell Carcinoma of the Anal Canal Care
Brian P. McDonough, MD, FAAFP
Madison Conces, MD
Midhun Malla, MD
ctDNA-Guided Adjuvant Atezolizumab in MIBC: IMvigor011 Insights
Project Oncology®ctDNA-Guided Adjuvant Atezolizumab in MIBC: IMvigor011 Insights
Charles Turck, PharmD, BCPS, BCCCP
Guru P. Sonpavde, MD
How Colorectal Cancer Screening Fits into OB/GYN Care
Clinician's RoundtableHow Colorectal Cancer Screening Fits into OB/GYN Care
Mallik Greene, PhD
- advertisement
David T. Rubin, MD
Michael Dolinger, MD, MBA
Florence Odufalu, MD
Ugonna Iroku, MD, MHS
Sharon Dudley-Brown, PhD, FNP-BC, FAAN, FAANP
IBD Beyond Symptoms: What Community GIs Need to Know
MinuteCE®IBD Beyond Symptoms: What Community GIs Need to Know
David T. Rubin, MD
Ugonna Iroku, MD, MHS
Florence Odufalu, MD
Targeting Inflammation in IBD: Localized vs Systemic Strategies
MinuteCE®Targeting Inflammation in IBD: Localized vs Systemic Strategies
David T. Rubin, MD
Michael Dolinger, MD, MBA
Beyond Biology: Environmental and Lifestyle Influences in IBD
MinuteCE®Beyond Biology: Environmental and Lifestyle Influences in IBD
Sharon Dudley-Brown, PhD, FNP-BC, FAAN, FAANP
Florence Odufalu, MD
Understanding the Microbiome’s Role in IBD Management
MinuteCE®Understanding the Microbiome’s Role in IBD Management
Florence Odufalu, MD
- advertisement
On the Frontline: Empowering IO Therapies for Patients with HER2-Negative G/GEJC
Project Oncology®On the Frontline: Empowering IO Therapies for Patients with HER2-Negative G/GEJC
Charles Turck, PharmD, BCPS, BCCCP
Jun Gong, MD
Harnessing the Immune Power: A Uniquely Designed PD-1 Inhibitor for Esophageal Cancer
Project Oncology®Harnessing the Immune Power: A Uniquely Designed PD-1 Inhibitor for Esophageal Cancer
Charles Turck, PharmD, BCPS, BCCCP
Jaffer Ajani, MD
Diagnosing IBS-C: From Clinical Clues to Confident Calls
Clinician's RoundtableDiagnosing IBS-C: From Clinical Clues to Confident Calls
Darren Brenner, MD
Kyle Staller, MD, MPH
An Expert’s Approach to a Difficult-to-Manage Condition: Breaking the rCDI Cycle with a Microbiome-Focused Strategy
Medical Industry FeatureAn Expert’s Approach to a Difficult-to-Manage Condition: Breaking the rCDI Cycle with a Microbiome-Focused Strategy
Paul Feuerstadt, MD, FACG, AGAF
Rise in Early-Onset Colon Cancer Being Studied Through Single-Cell Sequencing
Medical Industry FeatureRise in Early-Onset Colon Cancer Being Studied Through Single-Cell Sequencing
Joel Gabre, M.D, MPH
Pioneering a First in Robotic Liver Transplant
Medical Industry FeaturePioneering a First in Robotic Liver Transplant
Juan P. Rocca, M.D., MHA
- 05/08/2026
- 05/06/2026
- 05/05/2026
- 05/04/2026
- 05/04/2026
- 05/04/2026